Literature DB >> 33480178

Modeling autosomal dominant Alzheimer's disease with machine learning.

Patrick H Luckett1, Austin McCullough1, Brian A Gordon1, Jeremy Strain1, Shaney Flores1, Aylin Dincer1, John McCarthy1, Todd Kuffner1, Ari Stern1, Karin L Meeker1, Sarah B Berman2, Jasmeer P Chhatwal3, Carlos Cruchaga1, Anne M Fagan1, Martin R Farlow4, Nick C Fox5, Mathias Jucker6, Johannes Levin7,8,9, Colin L Masters10, Hiroshi Mori11, James M Noble12, Stephen Salloway13, Peter R Schofield14,15, Adam M Brickman16, William S Brooks14,15, David M Cash5, Michael J Fulham17,18, Bernardino Ghetti4, Clifford R Jack19, Jonathan Vöglein8,20, William Klunk2, Robert Koeppe21, Hwamee Oh13, Yi Su22, Michael Weiner23, Qing Wang1, Laura Swisher1, Dan Marcus1, Deborah Koudelis1, Nelly Joseph-Mathurin1, Lisa Cash1, Russ Hornbeck1, Chengjie Xiong1, Richard J Perrin1, Celeste M Karch1, Jason Hassenstab1, Eric McDade1, John C Morris1, Tammie L S Benzinger1, Randall J Bateman1, Beau M Ances1.   

Abstract

INTRODUCTION: Machine learning models were used to discover novel disease trajectories for autosomal dominant Alzheimer's disease.
METHODS: Longitudinal structural magnetic resonance imaging, amyloid positron emission tomography (PET), and fluorodeoxyglucose PET were acquired in 131 mutation carriers and 74 non-carriers from the Dominantly Inherited Alzheimer Network; the groups were matched for age, education, sex, and apolipoprotein ε4 (APOE ε4). A deep neural network was trained to predict disease progression for each modality. Relief algorithms identified the strongest predictors of mutation status.
RESULTS: The Relief algorithm identified the caudate, cingulate, and precuneus as the strongest predictors among all modalities. The model yielded accurate results for predicting future Pittsburgh compound B (R2  = 0.95), fluorodeoxyglucose (R2  = 0.93), and atrophy (R2  = 0.95) in mutation carriers compared to non-carriers. DISCUSSION: Results suggest a sigmoidal trajectory for amyloid, a biphasic response for metabolism, and a gradual decrease in volume, with disease progression primarily in subcortical, middle frontal, and posterior parietal regions.
© 2021 the Alzheimer's Association.

Entities:  

Keywords:  Pittsburgh compound B (PiB); autosomal dominant Alzheimer's disease (ADAD); fluorodeoxyglucose (FDG); machine learning; magnetic resonance imaging (MRI)

Mesh:

Substances:

Year:  2021        PMID: 33480178      PMCID: PMC8195816          DOI: 10.1002/alz.12259

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   16.655


  39 in total

1.  Longitudinal cognitive and biomarker changes in dominantly inherited Alzheimer disease.

Authors:  Eric McDade; Guoqiao Wang; Brian A Gordon; Jason Hassenstab; Tammie L S Benzinger; Virginia Buckles; Anne M Fagan; David M Holtzman; Nigel J Cairns; Alison M Goate; Daniel S Marcus; John C Morris; Katrina Paumier; Chengjie Xiong; Ricardo Allegri; Sarah B Berman; William Klunk; James Noble; John Ringman; Bernardino Ghetti; Martin Farlow; Reisa A Sperling; Jasmeer Chhatwal; Stephen Salloway; Neill R Graff-Radford; Peter R Schofield; Colin Masters; Martin N Rossor; Nick C Fox; Johannes Levin; Mathias Jucker; Randall J Bateman
Journal:  Neurology       Date:  2018-09-14       Impact factor: 9.910

Review 2.  Machine Learning for Medical Imaging.

Authors:  Bradley J Erickson; Panagiotis Korfiatis; Zeynettin Akkus; Timothy L Kline
Journal:  Radiographics       Date:  2017-02-17       Impact factor: 5.333

3.  The distribution of amyloid beta protein deposition in the corpus striatum of patients with Alzheimer's disease.

Authors:  M J Brilliant; R J Elble; M Ghobrial; R G Struble
Journal:  Neuropathol Appl Neurobiol       Date:  1997-08       Impact factor: 8.090

Review 4.  FreeSurfer.

Authors:  Bruce Fischl
Journal:  Neuroimage       Date:  2012-01-10       Impact factor: 6.556

5.  The Clinical Dementia Rating (CDR): current version and scoring rules.

Authors:  J C Morris
Journal:  Neurology       Date:  1993-11       Impact factor: 9.910

6.  Neuronal hyperactivity--A key defect in Alzheimer's disease?

Authors:  Marc Aurel Busche; Arthur Konnerth
Journal:  Bioessays       Date:  2015-03-14       Impact factor: 4.345

7.  Application of advanced machine learning methods on resting-state fMRI network for identification of mild cognitive impairment and Alzheimer's disease.

Authors:  Ali Khazaee; Ata Ebrahimzadeh; Abbas Babajani-Feremi
Journal:  Brain Imaging Behav       Date:  2016-09       Impact factor: 3.978

8.  Application of Machine Learning to Arterial Spin Labeling in Mild Cognitive Impairment and Alzheimer Disease.

Authors:  Lyduine E Collij; Fiona Heeman; Joost P A Kuijer; Rik Ossenkoppele; Marije R Benedictus; Christiane Möller; Sander C J Verfaillie; Ernesto J Sanz-Arigita; Bart N M van Berckel; Wiesje M van der Flier; Philip Scheltens; Frederik Barkhof; Alle Meije Wink
Journal:  Radiology       Date:  2016-07-06       Impact factor: 11.105

9.  Clinical and biomarker changes in dominantly inherited Alzheimer's disease.

Authors:  Randall J Bateman; Chengjie Xiong; Tammie L S Benzinger; Anne M Fagan; Alison Goate; Nick C Fox; Daniel S Marcus; Nigel J Cairns; Xianyun Xie; Tyler M Blazey; David M Holtzman; Anna Santacruz; Virginia Buckles; Angela Oliver; Krista Moulder; Paul S Aisen; Bernardino Ghetti; William E Klunk; Eric McDade; Ralph N Martins; Colin L Masters; Richard Mayeux; John M Ringman; Martin N Rossor; Peter R Schofield; Reisa A Sperling; Stephen Salloway; John C Morris
Journal:  N Engl J Med       Date:  2012-07-11       Impact factor: 91.245

10.  Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease.

Authors:  Randall J Bateman; Paul S Aisen; Bart De Strooper; Nick C Fox; Cynthia A Lemere; John M Ringman; Stephen Salloway; Reisa A Sperling; Manfred Windisch; Chengjie Xiong
Journal:  Alzheimers Res Ther       Date:  2011-01-06       Impact factor: 6.982

View more
  4 in total

1.  Biomarker clustering in autosomal dominant Alzheimer's disease.

Authors:  Patrick H Luckett; Charlie Chen; Brian A Gordon; Julie Wisch; Sarah B Berman; Jasmeer P Chhatwal; Carlos Cruchaga; Anne M Fagan; Martin R Farlow; Nick C Fox; Mathias Jucker; Johannes Levin; Colin L Masters; Hiroshi Mori; James M Noble; Stephen Salloway; Peter R Schofield; Adam M Brickman; William S Brooks; David M Cash; Michael J Fulham; Bernardino Ghetti; Clifford R Jack; Jonathan Vöglein; William E Klunk; Robert Koeppe; Yi Su; Michael Weiner; Qing Wang; Daniel Marcus; Deborah Koudelis; Nelly Joseph-Mathurin; Lisa Cash; Russ Hornbeck; Chengjie Xiong; Richard J Perrin; Celeste M Karch; Jason Hassenstab; Eric McDade; John C Morris; Tammie L S Benzinger; Randall J Bateman; Beau M Ances
Journal:  Alzheimers Dement       Date:  2022-04-01       Impact factor: 16.655

2.  A double-dichotomy clustering of dual pathology dementia patients.

Authors:  Arvind Caprihan; Rajikha Raja; Laura J Hillmer; Erik Barry Erhardt; Jill Prestopnik; Jeffrey Thompson; John C Adair; Janice E Knoefel; Gary A Rosenberg
Journal:  Cereb Circ Cogn Behav       Date:  2021-04-02

Review 3.  The Road to Personalized Medicine in Alzheimer's Disease: The Use of Artificial Intelligence.

Authors:  Anuschka Silva-Spínola; Inês Baldeiras; Joel P Arrais; Isabel Santana
Journal:  Biomedicines       Date:  2022-01-29

4.  APP, PSEN1, and PSEN2 Variants in Alzheimer's Disease: Systematic Re-evaluation According to ACMG Guidelines.

Authors:  Xuewen Xiao; Hui Liu; Xixi Liu; Weiwei Zhang; Sizhe Zhang; Bin Jiao
Journal:  Front Aging Neurosci       Date:  2021-06-18       Impact factor: 5.750

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.